TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 1,367 | 1,290 | 1,292 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 739 | 362 | 219 |
EBITDA | 707 | 359 | 219 |
Total assets | 2,222 | 2,191 | 2,386 |
Current assets | 2,222 | 2,191 | 2,386 |
Current liabilities | 24 | 15 | 195 |
Equity capital | 2,140 | 2,110 | 2,125 |
- share capital | 50 | 50 | 50 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 96.3% | 96.3% | 89.1% |
Turnover per employee | 1,367 | 1,290 | 1,292 |
Profit as a percentage of turnover | 54.1% | 28.1% | 17.0% |
Return on assets (ROA) | 33.3% | 16.5% | 9.2% |
Current ratio | 9258.3% | 14606.7% | 1223.6% |
Return on equity (ROE) | 34.5% | 17.2% | 10.3% |
Change turnover | 77 | -2 | -594 |
Change turnover % | 6% | 0% | -31% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.